Tylš, F., Páleníček, T., & Horáček, J. (2014). Psilocybin – summary of knowledge and new perspectives. European Neuropsychopharmacology, 24(3), 342–356. https://doi.org/10.1016/j.euroneuro.2013.12.006 

Alma College

Research dating back to the late 50s has provided evidence of how this substance seems to be a relatively safe central nervous system-acting drug in healthy subjects, in which the therapeutic effects can outweigh the risks considering its low potential of abuse. 

Advantages of psilocybin use in psycho-therapy

Psilocybin – summary of knowledge and new perspectives. European Neuropsychopharmacology,

Clinicians prescribe medications such as antidepressants and other approved pharmacological resources that seem to be not completely significant, as there are further considerations that prevent the longevity of use as well as the withdrawal factor.  In addition, factors such as the increased risk of attempting suicide which is presented in antidepressants are not reported in clinical trials in which psilocybin is used.

Psylocibin-assisted therapy could become a more successful treatment for mood disorders in patients with terminal illnesses than currently approved treatments

Learn Before

Related